Education
About Us
Working with TipRanks
Follow Us
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
RESEARCH TOOLSreports
ACRV Analyst Ratings
Strong Buy
8 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ACRV Stock 12 Month Forecast
Average Price Target
$12.00
▲(900.00%Upside)
| Highest Price Target$19.00 | Average Price Target$12.00 | Lowest Price Target$6.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Maxim Group
$7
Buy
483.33%
Upside
Reiterated
05/20/25
JonesTrading
―
Hold
―
Downgraded
05/16/25
H.C. Wainwright
$19
Buy
1483.33%
Upside
Reiterated
05/15/25
Oppenheimer
$10→$9
Buy
650.00%
Upside
Reiterated
05/15/25
Cantor Fitzgerald
―
Buy
―
Reiterated
05/15/25
Piper Sandler
$6
Buy
400.00%
Upside
Reiterated
05/15/25
TD Cowen
―
Buy
―
Reiterated
05/14/25
Citizens JMP
$17→$13
Buy
983.33%
Upside
Reiterated
03/28/25
Jefferies
$18
Buy
1400.00%
Upside
Assigned
03/26/25
Ladenburg Thalmann & Co.
$16
Buy
1233.33%
Upside
Upgraded
09/16/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Maxim Group
$7
Buy
483.33%
Upside
Reiterated
05/20/25
JonesTrading
―
Hold
―
Downgraded
05/16/25
H.C. Wainwright
$19
Buy
1483.33%
Upside
Reiterated
05/15/25
Oppenheimer
$10→$9
Buy
650.00%
Upside
Reiterated
05/15/25
Cantor Fitzgerald
―
Buy
―
Reiterated
05/15/25
Piper Sandler
$6
Buy
400.00%
Upside
Reiterated
05/15/25
TD Cowen
―
Buy
―
Reiterated
05/14/25
Citizens JMP
$17→$13
Buy
983.33%
Upside
Reiterated
03/28/25
Jefferies
$18
Buy
1400.00%
Upside
Assigned
03/26/25
Ladenburg Thalmann & Co.
$16
Buy
1233.33%
Upside
Upgraded
09/16/24
Best Analysts Covering Acrivon Therapeutics, Inc.
1 Month
xxx
Success Rate
4/9 ratings generated profit
Average Return
-1.99%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 44.44% of your transactions generating a profit, with an average return of -1.99% per trade.
3 Months
xxx
Success Rate
3/9 ratings generated profit
Average Return
-9.18%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -9.18% per trade.
1 Year
Success Rate
2/9 ratings generated profit
Average Return
-47.94%
reiterated a buy rating last month
Copying Marc Frahm's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -47.94% per trade.
2 Years
xxx
Success Rate
1/9 ratings generated profit
Average Return
-65.48%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -65.48% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ACRV Analyst Recommendation Trends
Rating
Nov 24
Jan 25
Mar 25
Apr 25
May 25
Strong Buy
18
8
10
6
11
Buy
2
2
4
3
4
Hold
0
0
1
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
10
15
10
17
Each month's total comprises the sum of three months' worth of ratings.
ACRV Financial Forecast
ACRV Stock Forecast FAQ
What is ACRV’s average 12-month price target, according to analysts?
Based on analyst ratings, Acrivon Therapeutics, Inc.’s 12-month average price target is 12.00.
What is ACRV’s upside potential, based on the analysts’ average price target?
Acrivon Therapeutics, Inc. has 900.00% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ACRV a Buy, Sell or Hold?
Acrivon Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
What is Acrivon Therapeutics, Inc.’s price target?
The average price target for Acrivon Therapeutics, Inc. is 12.00. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $19.00 ,the lowest forecast is $6.00. The average price target represents 900.00% Increase from the current price of $1.2.
The highest analyst price target is $19.00 ,the lowest forecast is $6.00. The average price target represents 900.00% Increase from the current price of $1.2.
What do analysts say about Acrivon Therapeutics, Inc.?
Acrivon Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of ACRV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.